In particular, autophagy has been shown to promote the survival of cancer cells treated with PARP inhibitors by removing damaged proteins and organelles, thereby reducing the accumulation of toxic cellular debris and promoting cell survival [43,59]. Here, PARP1 is linked to cancer.